Mass GIC Medicare GLP-1 coverage in 2027: weight-loss cover ends
By John Samaras, price analyst · Prices checked Nov 16, 2026
Massachusetts Group Insurance Commission (GIC) health plans end coverage of GLP-1s prescribed for obesity alone on December 31, 2026 for Medicare plan members. From January 1, 2027 that coverage is gone. Non-Medicare members lost it on June 30, 2026.
What it costs without insurance
If Medicare won't cover it for weight loss
Eden$99 a monthIncludes medication, provider review and shippingCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Who this affects
Medicare plan members of GIC health plans who take a GLP-1 for weight loss alone. Members who take one for diabetes are not part of this change.
When it starts
Coverage ends on December 31, 2026. The first day without it is January 1, 2027.
If you lose coverage: cash now
Two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a monthCheck price →Eden's GLP-1 page, then an online assessment
- Check price →
- Compounded semaglutide and tirzepatide prices, from $59 a month
- Find your GLP-1 program in four questions
What the GIC update says
Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end
- The GIC dates the end at December 31, 2026 for Medicare plan members and June 30, 2026 for non-Medicare members.
- In its July 1, 2026 changes the GIC kept coverage for GLP-1s used for diabetes and for members with a BMI of 27 or higher and an FDA-approved comorbidity.
- Since July 1, 2026, GLP-1 prescriptions go through members' own doctors and need prior authorization through CVS.
- Vida Health runs through December 31, 2026 without prescribing, for coaching and dietitian visits, and the GIC says it will help members find direct-pay options once coverage ends.
- CMS says anyone who filled a GLP-1 through a Part D plan in 2026, extra weight-loss coverage included, is not eligible for the Medicare GLP-1 Bridge in 2026. CMS has not yet set its 2027 lookback.
Sources:
- Mass.gov, Group Insurance Commission: Update on Vida Health Program and GLP-1 Coverage, dated April 14, 2026, read November 15, 2026 from the Internet Archive copy.
- CMS, Medicare GLP-1 Bridge: information for Part D plans, dated August 6, 2026, read November 15, 2026.
What to do before January 1
- Ask your GIC plan whether your prescription is on file for diabetes or another covered condition before January.
- Check the Medicare GLP-1 Bridge rules, including the 2027 lookback once CMS sets it.
- Compare the cash routes on this page before your last covered fill.
The Medicare GLP-1 Bridge in 2027. Medicare GLP-1 Bridge checker.
What cash costs today
Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.
Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.
| Cash route | Monthly price | Checked |
|---|---|---|
| Compounded semaglutide | From $59 | November 16, 2026 |
| Compounded tirzepatide | From $69 | November 16, 2026 |
| Wegovy pill from NovoCare | From $149 at the 1.5mg starter dose | November 16, 2026 |
| Zepbound vial from LillyDirect | From $299 at 2.5mg | November 16, 2026 |
Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.
Frequently asked questions
When does GIC Medicare stop covering Wegovy for weight loss?
Did non-Medicare GIC members keep any GLP-1 coverage?
Can GIC Medicare members use the Medicare GLP-1 Bridge?
Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.